What is CBD Water? (Can it get you high?)

If you've ever heard about CBD water and wondered, "What is CBD water?" - you're not alone! It's a trendy topic these days, and we're here to break it down for you in simple terms:

CBD water is exactly what it sounds like - water infused with CBD, short for cannabidiol. CBD is a natural compound found in hemp plants. Unlike its cousin THC (tetrahydrocannabinol), CBD is non-psychoactive, meaning it won't get you high.

But, it may have lots of benefits that make it worth your while. We’ll cover everything you need to know about CBD water, including its effects, benefits, drawbacks, and more. 

Let’s jump in:

Table of Contents
How is CBD Water Made?
Can CBD Water Get You High?
Benefits of CBD Water?
Why CBD Water?
Conclusion
Resources

Key Takeaways

• CBD water is water infused with CBD, a non-psychoactive compound from hemp plants.
• It won't get you high because it lacks THC, the psychoactive component found in cannabis.
• CBD water offers quick absorption, hydration, and convenient consumption.

How is CBD Water Made?

Creating CBD water involves using nanotechnology to make tiny CBD particles that are water-soluble. These microscopic CBD particles mix easily with water, resulting in a CBD-infused beverage that's easy to consume and absorb into the body. 

Traditional CBD oil products make CBD water an impossible feat. Ever tried mixing oil and water? Not the best combo, right? Well, this technology overcomes that problem, ensuring that the CBD remains evenly distributed throughout the water.

Can CBD Water Get You High?

Short answer: No, CBD water can't get you high. The psychoactive effects associated with cannabis come from THC, not CBD. So, feel free to sip your CBD water without worrying about unexpected trips to the stratosphere!

Benefits of CBD Water

Now that we've answered the pressing question "What is CBD water?" Let's delve into the potential benefits of CBD. Keep in mind that research is ongoing and CBD supplements have not been proven effective for the treatment of any condition. 

Most research is still in its infancy, but studies show that CBD may have potential in the following areas:

• Autoimmune diseases: Preliminary research has shown that CBD may have benefits that are useful for managing a variety of autoimmune disorders, including Multiple Sclerosis, Rheumatoid Arthritis, and Psoriasis.
• Bowel Disease: Certain bowel diseases are considered “qualifying conditions” for medical marijuana in areas where medicinal use is legal. More recently, studies have identified some positive potential benefits of CBD for Inflammatory Bowel Diseases, like Colitis.
• Metabolic Syndrome:Some research suggests that CBD may have a positive impact on insulin resistance and diabetes. Other research identifies it as a potential treatment for obesity through increased “fat browning,” which may lead to weight loss.
• Neurological conditions: CBD has been identified as potentially having significant neuroprotective properties, and it has been studied for its potential benefits for childhood epilepsy, Alzheimer’s Disease, and a variety of neurodegenerative disorders.
• Pain: In general, much of the research surrounding CBD focuses on the cannabinoid’s potential ability to manage pain. Research suggests CBD may block pain signals, which may make it a candidate for difficult to manage pain, neuropathic pain, and more.
• Psychological Disorders: Some research suggests CBD may have the ability to improve cognitive function. For this reason, researchers are interested in CBD's ability to potentially help manage a variety of psychological and neuropsychiatric disorders, like anxiety, depression, ADHD, PTSD, and chemical dependency.
• Skin Conditions:Many skin conditions may be linked to an endocannabinoid deficiency, and current research suggests CBD may impact skin conditions like psoriasis and eczema. Similarly, studies have identified potential anti-inflammatory, anti-bacterial, and sebostatic properties that may make CBD a good treatment for acne and other skin irritations.
• Sleep Disorders: Interest surrounds CBD’s potential ability to improve certain sleep disorders, namely anxiety-induced insomnia.

Although there is plenty of research surrounding the benefits of CBD, some of which dates back decades, legal restrictions have kept the pharmaceutical industry from advancing cannabinoid-based medicines until recently.

With new legal guidelines and increased access, CBD research is expected to continue to expand, leading to new approved pharmaceutical uses for CBD.

Why CBD Water? (Compared to Other CBD Dosing Methods)

You may be wondering–why would I choose CBD water over other types of CBD products, like CBD oil, capsules, edibles, or flower? The answer is that it mostly depends on your preference, but here are a few proposed benefits of CBD water when compared to some other dosing methods:

• Quick Absorption:The nanotechnology used in CBD water allows for faster absorption, potentially providing quicker relief compared to some other CBD products.
• Hydration Plus CBD: It combines the hydrating benefits of water with the potential health perks of CBD, offering a dual-action beverage for those looking to stay refreshed and enjoy potential wellness effects.
• Convenience:CBD water is easy to consume on the go. Just grab a bottle, and you're set!

That said, CBD water is usually a more expensive dosing method when compared to bulk options, like a CBD tincture or bottle of CBD edibles. Plus, you can get the same quick-absorption (plus long-lasting benefits) from a sublingual-style CBD edible. 

Wrapping Up

So, the next time someone asks you, "What is CBD water?", you can confidently explain that it's water infused with CBD, a non-psychoactive compound derived from hemp plants. It won't get you high, but it might just hydrate you with a sprinkle of potential wellness benefits.

If you’re looking for high-quality, federally legal CBD products, check out our Vitality CBD Collection. It pairs premium, full-spectrum CBD with essential vitamins for a hearty daily dose in a variety of potencies and flavors. All Vida Optima products are 100% Farm Bill Compliant. Read “Where is CBD Legal?” to get to know the CBD hemp laws in your state. 

Resources

1. “Meet CBG, the New Cannabinoid on the Block” https://www.healthline.com/health/cbg-oil#:~:text=While%20the%20research%20on%20CBG,2013%20study%20conducted%20on%20mice%20.
2. “Why CBG (Cannabigerol) Is One Of The Most Expensive Cannabinoids To Produce” https://www.forbes.com/sites/janellelassalle/2019/09/11/why-cbg-cannabigerol-expensive-produce/#736a1e462f77
3. “Research Shows 9 Potential Health Benefits of CBN” https://www.psychologytoday.com/us/blog/sleep-newzzz/201908/research-shows-9-potential-health-benefits-cbn
4. “Cannabis study reveals how CBD offsets the psychiatric side-effects of THC” https://www.sciencedaily.com/releases/2019/09/190930131115.htm
5. “Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects” https://www.researchgate.net/publication/16911686_Action_of_cannabidiol_on_the_anxiety_and_other_effects_produced_by_delta_9-THC_in_normal_subjects
6. “2018 Farm Bill” https://www.agriculture.senate.gov/2018-farm-bill
7. “Human Endocannabinoid System” https://www.uclahealth.org/cannabis/human-endocannabinoid-system
8. “Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576607/
9. “Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085417/
10. “Joints for Joints: Cannabinoids in the Treatment of Rheumatoid Arthritis” https://pubmed.ncbi.nlm.nih.gov/30920973/
11. “Cannabis for Refractory Psoriasis-High Hopes for a Novel Treatment and a Literature Review” https://pubmed.ncbi.nlm.nih.gov/27164964/
12. “CBD Could Treat Inflammatory Bowel Disease, Says New Study” https://www.analyticalcannabis.com/articles/cbd-could-treat-inflammatory-bowel-disease-says-new-study-311677
13. “Cannabidiol, a Safe and Non-Psychotropic Ingredient of the Marijuana Plant Cannabis Sativa, Is Protective in a Murine Model of Colitis” https://pubmed.ncbi.nlm.nih.gov/19690824/
14. “The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults” https://www.amjmed.com/article/S0002-9343%2813%2900200-3/abstract
15. “Cannabidiol Promotes Browning in 3T3-L1 Adipocytes” https://pubmed.ncbi.nlm.nih.gov/27067870/
16. “Report of a Parent Survey of Cannabidiol-Enriched Cannabis Use in Pediatric Treatment-Resistant Epilepsy” https://pubmed.ncbi.nlm.nih.gov/24237632/
17. “Neuroprotective Effect of Cannabidiol, a Non-Psychoactive Component From Cannabis Sativa, on Beta-Amyloid-Induced Toxicity in PC12 Cells” https://pubmed.ncbi.nlm.nih.gov/15030397/
18. “Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?” https://www.theroc.us/researchlibrary/Cannabidiol%20for%20neurodegenerative%20disorders-%20important%20new%20clinical%20applications%20for%20this%20phytocannabinoid.pdf
19. “Cannabinoids in the management of difficult to treat pain” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
20. “Meta-analysis of Cannabis Based Treatments for Neuropathic and Multiple Sclerosis-Related Pain” https://pubmed.ncbi.nlm.nih.gov/17257464/
21. “Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial” https://pubmed.ncbi.nlm.nih.gov/29607408/
22. “Cannabidiol, a Cannabis Sativa Constituent, as an Anxiolytic Drug” https://pubmed.ncbi.nlm.nih.gov/22729452/
23. “Antidepressant-like Effects of Cannabidiol in Mice: Possible Involvement of 5-HT1A Receptors” https://pubmed.ncbi.nlm.nih.gov/20002102/
24. “Cannabidiol and Clozapine Reverse MK-801-induced Deficits in Social Interaction and Hyperactivity in Sprague-Dawley Rats” https://pubmed.ncbi.nlm.nih.gov/22495620/
25. “Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
26. “Cannabis for Refractory Psoriasis-High Hopes for a Novel Treatment and a Literature Review” https://pubmed.ncbi.nlm.nih.gov/27164964/
27. “Cannabidiol Exerts Sebostatic and Antiinflammatory Effects on Human Sebocytes” https://pubmed.ncbi.nlm.nih.gov/25061872/
28. “Cannabidiol in Anxiety and Sleep: A Large Case Series” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
29. “FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy” https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms
30. “Sativex – Investigational Cannabis-Based treatment for Pain and Multiple Sclerosis” https://www.clinicaltrialsarena.com/projects/sativex/
31. “Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder” https://clinicaltrials.gov/ct2/show/NCT04197102?recrs=a
32. “Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia (CBD)” https://clinicaltrials.gov/ct2/show/NCT04075435?recrs=a
33. “Cannabidiol for ASD Open Trial” https://clinicaltrials.gov/ct2/show/NCT03900923?recrs=a
34. “The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
35. “Russian roulette’: Investigation finds CBD products spiked with illegal synthetic marijuana” https://nypost.com/2019/09/17/russian-roulette-investigation-finds-cbd-products-spiked-with-illegal-synthetic-marijuana/
36. “Warning Letters and Test Results for Cannabidiol-Related Products” https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products
37. “An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
38. “CANNABIDIOL (CBD) Pre-Review Report Agenda Item 5.2“ https://www.who.int/medicines/access/controlled-substances/5.2_CBD.pdf